Loading...

Critic at Large

» culture, disease/medicine and science publishing

Most Recent

image: Misconduct Around the Globe

Misconduct Around the Globe

By Richard Smith and Tracey Koehlmoos | June 1, 2013

Research misconduct is not limited to the developed world, but few countries anywhere are responding adequately.

3 Comments

image: Cancer Clinical Trials of Tomorrow

Cancer Clinical Trials of Tomorrow

By Tomasz M. Beer | April 1, 2013

Advances in genomics and cancer biology will alter the design of human cancer studies.

0 Comments

image: Genomics-Informed Pathology

Genomics-Informed Pathology

By Dennis P. Wall and Peter J. Tonellato | January 1, 2013

Twenty-first century lab reports will include test results read by a new breed of pathologist.

1 Comment

image: Military Mind Wars

Military Mind Wars

By Jonathan D. Moreno | November 1, 2012

How neuroscience research can inform military counterintelligence tactics, and the moral responsibilities that accompany such research

5 Comments

image: Medicines for the World

Medicines for the World

By Suerie Moon and Ellen ’t Hoen | October 1, 2012

A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.

0 Comments

image: Bring On the Transparency Index

Bring On the Transparency Index

By Adam Marcus and Ivan Oransky | August 1, 2012

Grading journals on how well they share information with readers will help deliver accountability to an industry that often lacks it.

6 Comments

image: Predatory Publishing

Predatory Publishing

By Jeffrey Beall | August 1, 2012

Overzealous open-access advocates are creating an exploitative environment, threatening the credibility of scholarly publishing.

32 Comments

image: All’s Not Fair in Science and Publishing

All’s Not Fair in Science and Publishing

By Frederick Southwick | July 1, 2012

False credit for scientific discoveries threatens the success and pace of research.

72 Comments

image: Polypharmacy

Polypharmacy

By Catherine Ulbricht | July 1, 2012

Dietary supplements can have serious side effects when mixed with prescription drugs, but not all herb-drug interactions are bad.

14 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By Lisa A. Haile and Kimberly K. Egan | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

Popular Now

  1. Estonia Offers Free Genetic Testing to Residents
  2. Human Brain Organoids Thrive in Mouse Brains
  3. New Ovarian Cancer Vaccine Shows Promise
  4. The Second March for Science a Smaller Affair